Understand the source comparison
TB-4 Syringes Needles Supplies: Detailed Comparison
The right TB-4 syringes needles supplies determine reconstitution success and peptide bioavailability. This comparison breaks down needle gauge, syringe capacity, and supply functionality. Insulin syringe (29–31g, 0.5mL) 29–31 gauge, 5–8mm needle, 0.5mL capaci
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- The right TB-4 syringes needles supplies determine reconstitution success and peptide bioavailability. This comparison breaks down needle gauge, syringe capacity, and supply functionality.
- Insulin syringe (29–31g, 0.5mL)
- 29–31 gauge, 5–8mm needle, 0.5mL capacity
- Subcutaneous TB-4 injection for doses ≤0.5mL
- Ultra-fine gauge minimizes tissue trauma; low dead space reduces waste
- Best for standard TB-4 doses (0.2–0.5mL); precision markings ensure accurate dosing at research concentrations of 2–5mg/mL
- Insulin syringe (27–29g, 1.0mL)
- 27–29 gauge, 8–12mm needle, 1.0mL capacity
- Subcutaneous injection for higher-volume doses or lower concentrations
- Larger capacity accommodates dilute solutions; slightly thicker gauge reduces draw resistance
- Optimal for reconstituted TB-4 at 2mg/mL requiring 0.5–1.0mL per dose; easier to draw viscous solutions than 31g
- Drawing needle (18–21g)
- 18–21 gauge, 1.5 inch length
- Withdrawing bacteriostatic water from supply vial during reconstitution
- Wide bore prevents vacuum formation and allows fast, bubble-free draw
- Essential for efficient reconstitution; do not use for injection. Gauge is too large and causes unnecessary tissue damage
- Bacteriostatic water
- 0.9% benzyl alcohol in sterile water for injection
- Reconstitution solvent for lyophilised peptides
- Bacteriostatic agent prevents microbial growth for 28 days; maintains peptide stability
- Only acceptable solvent for multi-dose TB-4 vials; sterile water lacks preservative and must be discarded after single use
- Alcohol prep pads
- 70% isopropyl alcohol, individually sealed
- Sterilization of vial stoppers and injection sites
- Single-use sterile pads prevent cross-contamination
- Non-negotiable for every vial access and injection; reusable alcohol bottles introduce contamination risk
- Sterile gauze pads
- Non-woven, 2×2 inch, individually wrapped
- Post-injection site pressure application
- Absorbent without leaving fibers; sterile packaging prevents infection
- Preferred over cotton balls, which shed fibers that can adhere to injection sites